Coston McIsaac & Partners’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3K | Sell |
109
-1,170
| -91% | -$32.2K | ﹤0.01% | 663 |
|
|
2025
Q1 | $36K | Buy |
1,279
+1,160
| +975% | +$32.7K | 0.01% | 326 |
|
|
2024
Q4 | $4K | Hold |
119
| – | – | ﹤0.01% | 612 |
|
|
2024
Q3 | $7 | Sell |
119
-20
| -14% | -$1 | ﹤0.01% | 556 |
|
|
2024
Q2 | $16K | Hold |
139
| – | – | 0.01% | 406 |
|
|
2024
Q1 | $14K | Hold |
139
| – | – | ﹤0.01% | 437 |
|
|
2023
Q4 | $13K | Hold |
139
| – | – | ﹤0.01% | 449 |
|
|
2023
Q3 | $14K | Hold |
139
| – | – | 0.01% | 424 |
|
|
2023
Q2 | $16K | Hold |
139
| – | – | 0.01% | 442 |
|
|
2023
Q1 | $21K | Hold |
139
| – | – | 0.01% | 394 |
|
|
2022
Q4 | $24 | Hold |
139
| – | – | 0.01% | 383 |
|
|
2022
Q3 | $16K | Sell |
139
-7
| -5% | -$806 | 0.01% | 358 |
|
|
2022
Q2 | $21K | Buy |
+146
| New | +$21K | 0.01% | 201 |
|